Pages that link to "Q45126678"
Jump to navigation
Jump to search
The following pages link to Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. (Q45126678):
Displaying 50 items.
- Hepatitis C virus and type 2 diabetes (Q24658049) (← links)
- Hepatitis C Virus, Insulin Resistance, and Steatosis (Q26751755) (← links)
- Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality? (Q26776338) (← links)
- Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen (Q26861095) (← links)
- Metabolic factors and chronic hepatitis C: a complex interplay (Q27011787) (← links)
- Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis (Q27022707) (← links)
- Molecular mechanisms of insulin resistance in chronic hepatitis C (Q27489665) (← links)
- A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis (Q31157282) (← links)
- Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More (Q34172595) (← links)
- Insulin resistance and chronic liver disease (Q35073012) (← links)
- Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort (Q35136036) (← links)
- The interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C. (Q36042542) (← links)
- IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C. (Q36248186) (← links)
- Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study (Q36618416) (← links)
- Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus (Q37016775) (← links)
- Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study (Q37105110) (← links)
- Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection (Q37151984) (← links)
- Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3 (Q37155511) (← links)
- Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. (Q37201550) (← links)
- Hepatitis C and diabetes: the inevitable coincidence? (Q37432092) (← links)
- Fibrosis in Chronic Hepatitis C: Correlation between Immunohistochemically-Assessed Virus Load with Steatosis and Cellular Iron Content (Q37523542) (← links)
- Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C. (Q37607397) (← links)
- Interaction between hepatitis C virus and metabolic factors (Q37654443) (← links)
- Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review (Q37685491) (← links)
- Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications (Q37879191) (← links)
- Gallstones: Environment, Lifestyle and Genes (Q37898413) (← links)
- Current understanding of insulin resistance in hepatitis C. (Q37903853) (← links)
- Impact of HCV genetic differences on pathobiology of disease. (Q37929753) (← links)
- Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences (Q37962197) (← links)
- Host factors determining the efficacy of hepatitis C treatment. (Q38056077) (← links)
- Review article: genetic factors that modify the outcome of viral hepatitis (Q38198089) (← links)
- Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis (Q38572687) (← links)
- The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis. (Q40071098) (← links)
- Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C. (Q40707274) (← links)
- The association between chronic hepatitis C infection and cardiovascular risk. (Q40947117) (← links)
- Insulin resistance in euglycemic cirrhosis (Q41333484) (← links)
- Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance (Q41375331) (← links)
- SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS. (Q41928201) (← links)
- Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients (Q42102990) (← links)
- Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy (Q42181724) (← links)
- Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance (Q42990259) (← links)
- Insulin resistance and not steatosis is associated with modifications in oxidative stress markers in chronic hepatitis C, non-3 genotype (Q42992657) (← links)
- Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection. (Q42997700) (← links)
- Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients (Q43740937) (← links)
- Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection (Q45366869) (← links)
- Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. (Q46186152) (← links)
- Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial (Q50104601) (← links)
- Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis (Q50555948) (← links)
- A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease. (Q51377773) (← links)
- Hepatitis C Virus Infection Increases Risk of Gallstone Disease in Elderly Chinese Patients with Chronic Liver Disease. (Q55193643) (← links)